Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | KDR | P35968 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 10/20 | 0.51 |
| ▸ | NPC1 | O15118 | 9/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.51 |
| ▸ | LMNA | P02545 | 4/20 | 0.51 |
| ▸ | HTT | P42858 | 3/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | GFER | P55789 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | MITF | O75030 | 1/20 | 0.49 |
| ▸ | XBP1 | P17861 | 1/20 | 0.49 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.49 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2081815 | 0.98 | NPSR1 (0.60) | NPSR1KDRKDM4ECYP1A2RAB9A | |
| Hydrochloric Acid SCHEMBL8606417 | 0.98 | NPSR1 (0.60) | NPSR1KDRKDM4ECYP1A2RAB9A | |
| Hydrochloric Acid SCHEMBL25250658 | 0.98 | NPSR1 (0.60) | NPSR1KDRKDM4ECYP1A2RAB9A | |
| SCHEMBL30824513 | 0.80 | NPSR1 (0.57) | NPSR1KDRKDM4ECYP1A2RAB9A | |
| SCHEMBL128095 | 0.80 | NPSR1 (0.57) | NPSR1KDRKDM4ECYP1A2RAB9A | |
| SCHEMBL28007469 | 0.80 | NPSR1 (0.57) | NPSR1KDRKDM4ECYP1A2RAB9A | |
| SCHEMBL11591503 | 0.80 | NPSR1 (0.57) | NPSR1KDRKDM4ECYP1A2RAB9A | |
| SCHEMBL23055256 | 0.80 | NPSR1 (0.57) | NPSR1KDRKDM4ECYP1A2RAB9A | |
| SCHEMBL11591505 | 0.80 | NPSR1 (0.57) | NPSR1KDRKDM4ECYP1A2RAB9A | |
| SCHEMBL2111139 | 0.78 | KDM4E (0.58) | NPSR1KDRKDM4ECYP1A2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118109824-A | Carbon dioxide corrosion inhibitor based on Mannich base and preparation method and application thereof | 中国石油天然气集团有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-103626767-A | Azaindole with regionselectivity and synthetic method thereof | WUXI APPTEC CO LTD | 2014-03-12 | — | — | CN | claimed |
| US-6440896-B1 | FIRST DEVELOPER SOLUTION AND DISTINCT SECOND DEVELOPER SOLUTION PRODUCE DIFFERENT COLORS; COLOR STABILITY, WEAR RESISTANCE; INCORPORATING WITHIN A PROTECTIVE MEDIUM | EASTMAN KODAK COMPANY | 2002-08-27 | — | — | US | claimed |
| US-6197722-B1 | STORAGE STABILITY; IMAGES HAVING COLOR SATURATION AND COLOR GAMUT; INK JET PRINTING; NONSMEARING | EASTMAN KODAK COMPANY | 2001-03-06 | — | — | US | claimed |
| US-6143693-A | STORAGE STABILITY; ENABLES TO PRODUCE IMAGES HAVING COLOR SATURATION AND COLOR GAMUT, RESISTANCE TO DARK AND LIGHT FADE, RESISTANCE TO IMAGE SMEAR AND RUB-OFF, MOISTURE AND HUMIDITY RESISTANCE | EASTMAN KODAK COMPANY (US) | 2000-11-07 | — | — | US | claimed |
| CN-118109824-A | Carbon dioxide corrosion inhibitor based on Mannich base and preparation method and application thereof | 中国石油天然气集团有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-118109824-A | Carbon dioxide corrosion inhibitor based on Mannich base and preparation method and application thereof | 中国石油天然气集团有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-114540846-B | Synthesis method of 1,2, 4-triazolo six-membered nitrogen heterocycle-3-amine | 五邑大学 | 2023-09-19 | — | — | CN | disclosed |
| CN-114540846-A | Synthetic method of 1,2, 4-triazolo hexa-nitrogen heterocyclic-3-amine | 五邑大学 | 2022-05-27 | — | — | CN | disclosed |
| US-11306096-B2 | 4,6 dihydropyrrolo [3,4-C] pyrazole-5 (1H)-carbonitrile derivates for treating cancer | MISSION THERAPEUTICS LIMITED (GB) | 2022-04-19 | — | — | US | disclosed |
| EP-3430012-B1 | 4,6-DIHYDROPYRROLO[3,4-C]PYRAZOLE-5(1H)-CARBONITRILE DERIVATIVES FOR TREATING CANCER | MISSION THERAPEUTICS LTD (GB) | 2021-06-16 | — | — | EP | disclosed |
| CN-103626767-A | Azaindole with regionselectivity and synthetic method thereof | WUXI APPTEC CO LTD | 2014-03-12 | — | — | CN | disclosed |
| US-4975512-A | Crosslinking with amine, ammonium, hydrazine | PETROLEUM ENERGY CENTER (JP) | 1990-12-04 | — | — | US | disclosed |
| US-4970210-A | ENZYME INHIBITORS | ABBOTT LABORATORIES (US) | 1990-11-13 | — | — | US | disclosed |
| EP-0304239-A1 | Reformed polysilazane and method of producing same | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1989-02-22 | — | — | EP | disclosed |
| EP-0299449-A2 | Pyridazinone, triazinone and oxapyridazinone lipoxygenase inhibiting compounds | ABBOTT LABORATORIES (US) | 1989-01-18 | — | — | EP | disclosed |
| EP-0055418-B1 | PYRAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM | THE WELLCOME FOUNDATION LIMITED (GB) | 1986-02-26 | — | — | EP | disclosed |
| US-4524146-A | NERVOUS SYSTEM DISORDERS | CIBA-GEIGY CORPORATION (US) | 1985-06-18 | — | — | US | disclosed |
| EP-0055418-A2 | Pyrazoline derivatives, processes for their preparation and pharmaceutical formulations containing them | THE WELLCOME FOUNDATION LIMITED (GB) | 1982-07-07 | — | — | EP | disclosed |
| US-4094683-A | HETEROCYCLIC QUATERNARY AMMONIUM COMPOUND AS FOGGING AGENT | FUJI PHOTO FILM CO., LTD. (JA) | 1978-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11306096-B2 | 4,6 dihydropyrrolo [3,4-C] pyrazole-5 (1H)-carbonitrile derivates for treating cancer | USP7, USP1, USP3 | NPSR1 3538/4885KDR 4672/4885KDM4E 330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.